Healthtech & Diagnostics · Lab
Novo Genomics
What Novo Genomics says about itself
Novo Genomics is Saudi Arabia's first CAP-accredited genomics laboratory, headquartered in Riyadh and focused on localizing next-generation sequencing, multi-omics, and pharmacogenomics to support Vision 2030 precision medicine goals. The lab offers whole genome and whole exome sequencing, targeted gene panels, molecular diagnostics, genetic counseling, and non-invasive prenatal testing. It partnered with PGxAI to deploy AI-enabled pharmacogenomics across the Kingdom; CAP re-accreditation confirmed in 2025.
Source: novogenomics.sa, the organization's own site.
What the Atlas verified
Novo Genomics is one of 390 organizations recorded in the Atlas of the Healthspan Economy, one of 9 in Saudi Arabia and one of 54 in the Middle East.
As of August 1, 2026, Novo Genomics publishes no price for its programs on its own site.
Key people
- Dr. Budoor Almansour (Co-Founder and Chief Operating Officer)